Magnetic Immunoassay for Rapid Pathogen Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting bacterial pathogens are not sufficiently rapid, sensitive, or accurate for on-the-scene decision-making, particularly in low-concentration scenarios, and require significant user training and expensive equipment, making them unsuitable for portable and emergency use.
Innovation Solution
A magnetic immunoassay method that uses magnetic microparticles linked to antibodies to separate and detect bacterial pathogens by measuring glucose molecules attached to specific epitopes, allowing for rapid isolation and detection of pathogens in a fluid sample using conventional glucometer technology.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional biochemical detection methods are used, then reliability and measurement precision are improved, but detection time increases to at least thirty hours
Solution Approach 1:
The patent replaces traditional biochemical detection mechanisms with a magnetic field-based separation system. Magnetic microparticles coated with antibodies bind to pathogen epitopes, allowing rapid magnetic separation and detection within 30-45 minutes, eliminating the need for lengthy cultural incubation and biochemical testing procedures.
Solution Approach 2:
The invention changes the detection parameter from indirect biochemical signals to direct magnetic separation. By using magnetic microparticles that bind to pathogen-specific epitopes, the system transforms the detection process into a rapid physical separation that can be completed in under an hour, dramatically reducing detection time while maintaining accuracy.
2Productivity
If molecular detection methods like PCR are used, then detection speed and sensitivity are improved, but equipment complexity and operational difficulty increase
Solution Approach 1:
The patent employs disposable magnetic microparticles coated with antibodies as simple, single-use detection elements. These microparticles can be easily discarded after use, eliminating the need for expensive, complex molecular biology equipment and specialized training while achieving rapid detection results.
Solution Approach 2:
The invention introduces magnetic microparticles as intermediary elements between the sample and detection system. These microparticles bind to pathogen epitopes and can be separated using simple magnetic fields, serving as a bridge that simplifies the overall detection system and eliminates the need for complex PCR machinery.
3Measurement precision
If conventional ELISA methods are used, then sensitivity is improved to 10^5-10^7 bacterial cells/ml, but detection time requires overnight enrichment
Solution Approach 1:
The patent performs preliminary binding of magnetic microparticles to pathogen epitopes during the sample processing step itself, eliminating the need for separate overnight enrichment cultures. The magnetic separation and detection occur simultaneously with the binding reaction, reducing total detection time to 30-45 minutes while maintaining high sensitivity.
4Productivity
If rapid detection methods are developed for on-the-scene use, then detection speed is improved, but accuracy and reliability deteriorate
Solution Approach 1:
The invention applies local quality by using magnetic microparticles with specifically targeted antibody coatings that bind to unique pathogen epitopes. This localized molecular recognition ensures high accuracy in rapid detection, as the magnetic particles selectively bind only to the target pathogen while leaving other components unaffected, maintaining both speed and reliability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables rapid detection of bacterial pathogens within 30-45 minutes, improving sensitivity and accuracy, and can be adapted for portable use, overcoming the limitations of existing technologies by providing a user-friendly and cost-effective solution for pathogen detection.
Implementation Method 1
utilizing a magnetic field to separate the magnetic microparticle and linked targeted microorganism from at least a portion of other components in the fluid
Implementation Method 2
linking a magnetic microparticle to a first epitope of the target microorganism in a fluid via a first antibody
Implementation Method 3
detecting the glucose in the test sample to determine the presence or concentration of the target microorganism in the fluid
Data Source
AI summary
Assay systems and methods are provided for detecting a target pathogen, such as a microorganism (e.g., bacterium, bacterial toxin) which may be present in a fluid or other location. The method can include linking a magnetic microparticle to a first epitope of the target microorganism in a fluid via a first antibody; utilizing a magnetic field to separate the magnetic microparticle and linked targeted microorganism from at least a portion of other components in the fluid, thereby forming a test sample; linking a glucose molecule to a second epitope of the target microorganism via a second antibody; and detecting the glucose in the test sample to determine the presence or concentration of the target microorganism in the fluid. The glucose detection preferably is one that can be done rapidly, e.g., with a conventional glucometer, and may include measuring the electrical resistance, color, or pH of the test sample.